Isoprenylcysteine carboxyl methyltransferase (Icmt) methylates the carboxyl-terminal isoprenylcysteine of CAAX proteins (e.g., Ras and Rho proteins). In the case of the Ras proteins, carboxyl methylation is important for targeting of the proteins to the plasma membrane. We hypothesized that a knockout of Icmt would reduce the ability of cells to be transformed by K-Ras. Fibroblasts harboring a floxed Icmt allele and expressing activated K-Ras (K-Ras-Icmt flx/flx ) were treated with Cre-adenovirus, producing K-Ras-Icmt Δ/Δ fibroblasts. Inactivation of Icmt inhibited cell growth and K-Ras-induced oncogenic transformation, both in soft agar assays and in a nude mice model. The inactivation of Icmt did not affect growth factor-stimulated phosphorylation of Erk1/2 or Akt1. However, levels of RhoA were greatly reduced as a consequence of accelerated protein turnover. In addition, there was a large Ras/Erk1/2-dependent increase in p21 Cip1 , which was probably a consequence of the reduced levels of RhoA. Deletion of p21 Cip1 restored the ability of KRas-Icmt Δ/Δ fibroblasts to grow in soft agar. The effect of inactivating Icmt was not limited to the inhibition of K-Ras-induced transformation: inactivation of Icmt blocked transformation by an oncogenic form of B-Raf (V599E). These studies identify Icmt as a potential target for reducing the growth of K-Ras-and B-Raf-induced malignancies.
Introduction
Proteins that terminate with a carboxyl-terminal "CAAX" motif, such as the Ras and Rho proteins, undergo three sequential posttranslational processing events. First, the cysteine (i.e., the C of the CAAX sequence) is isoprenylated by protein farnesyltransferase (FTase) or geranylgeranyltransferase type I (GGTase I) (1) . Second, the last three amino acids of the protein (i.e., the -AAX) are cleaved off by Rce1, an integral membrane protein of the ER (2) . Third, the newly exposed isoprenylcysteine is methylated by an ER membrane-bound methyltransferase, isoprenylcysteine carboxyl methyltransferase (Icmt) (3) . These modifications render the C terminus of CAAX proteins more hydrophobic, facilitating binding to membranes (4) (5) (6) .
The posttranslational processing of CAAX proteins has attracted interest because of the central role of mutationally activated Ras proteins in the development of cancer (7, 8) . The enzymes that carry out the posttranslational modifications of CAAX proteins (i.e., FTase, GGTase I, Rce1, and Icmt) have been considered as potential targets for modulating the activity of the Ras proteins and for blocking the growth of Rasinduced malignancies. Farnesylation is critical for Ras activity (9) , and farnesyltransferase inhibitors (FTIs) have shown promise in treating tumors, both in experimental animals (10, 11) and in humans (12) (13) (14) (15) (16) (17) .
A potential drawback of the clinical use of FTIs is that K-Ras and N-Ras-the isoforms most often mutated in human tumors-can be efficiently geranylgeranylated in the setting of FTI therapy (18, 19) . This alternate prenylation of the Ras proteins could limit the efficacy of FTIs in the treatment of Ras-induced tumors. The existence of an alternate means for prenylation has led several groups to focus on the postisoprenylation steps mediated by Rce1 and Icmt, since those steps are shared by farnesylated and geranylgeranylated CAAX proteins (6) . We previously generated Rce1-knockout mice and found that they died quite late in gestation, after all of the major organ systems were formed (20) . The Ras proteins in Rce1-deficient fibroblasts were mislocalized away from the plasma membrane, and the cells grew slightly slower than wild-type cells (20) . More recently, we showed that the inactivation of Rce1 partially blocked transformation of cells by an activated form of H-Ras or K-Ras and sensitized transformed cells to the antiproliferative effects of an FTI (21) .
The phenotype of Icmt deficiency in mice was more severe than Rce1 deficiency; an Icmt knockout caused grossly retarded growth during embryonic development and death at embryonic day 10.5-11.5 (22) , possibly due to agenesis of the liver (23) . Icmt deficiency causes mislocalization of the Ras proteins within cells, but virtually nothing is known about the effects of Icmt deficiency on cell growth and oncogenic transformation. To address these issues, we created a conditional ("floxed") Icmt allele, generated fibroblast cell lines, and then analyzed the consequences of inactivating Icmt.
Methods

Production of a conditional Icmt allele.
To generate a conditional Icmt allele, exon 1 of Icmt along with upstream promoter sequences and parts of intron 1 were flanked with loxP sites. A 5′ arm of the gene-targeting vector (4 kb in length) was amplified from bacterial artificial chromosome DNA (24) with primers 5′-CTCTGTGCG-GCCGCCTGTGTATAACTGTTTCCTTAGGTATG-3′ and 5′-ACGACGGCGGCCGCCCGGCGACGCCGGCTCGGGA-AGGGC-3′ and cloned into the NotI site of pKSloxPNT (25) . A 2.1-kb 3′ arm was amplified with primers 5′-ACGACGGCGGCCGCAGGGTAGGTGCACCAGGTA-CATTAGAACCG-3′ and 5′-ACGACGGAATTCCTTCAGTT-CTGGCCAGAAGATGTTGTCGAGCG-3′ and cloned into the polylinker EcoRI site. A 717-bp fragment containing promoter sequences, exon 1, and parts of intron 1 was amplified with 5′-ACGACTATCGATTTGAATGCG-CAGGCCGGCCTTCGGGTTTCCC-3′ and 5′-ACGACG-GCGGCCGCATAACTTCGTATAATGTATGCTATAC-GAAGTTATGCCCCATCCCTGACTGATCGGTCCCTG-3′, which contained a loxP site. That fragment was inserted between the polylinker ClaI and BamHI sites. The vector was linearized with XhoI and electroporated into 129SV/Jae ES cells. ES cells were screened by Southern blotting; the genomic DNA was cleaved with BamHI, and the blots were hybridized with a 292-bp 5′-flanking probe (24) . Two targeted clones, each with a single integration event, were used to generate germlinetransmitting chimeric mice.
Primary fibroblasts were isolated from Icmt flx/flx embryos on day 15.5 post coitum (20, 26) . The cells were immortalized with a modified 3T3 protocol (26) or by transfecting the cells with E1A and activated human K-Ras (with a G12V activating mutation) (21, 27, 28) . For some experiments, the fibroblasts were also infected with a retrovirus encoding human K-Ras (G12V) and a puromycin-resistance cassette. Experiments were performed with two different K-Ras-transfected Icmt flx/flx cell lines (A and B), unless otherwise indicated. To produce B-Raf-transformed cell lines, spontaneously immortalized Icmt flx/flx fibroblasts were transfected with a retrovirus encoding an oncogenic form of human B-Raf (V599E) and a blasticidin-resistance cassette. Control cells were infected with a retrovirus encoding wild-type B-Raf. To inactivate Icmt (to produce Icmt ∆/∆ cells), Icmt flx/flx cells were infected with 10 8 PFU/ml of Cre-adenovirus (AdRSVCre). In parallel, control Icmt flx/flx cells were treated with 10 8 PFU/ml of a β-gal adenovirus (AdRSVnlacZ). The efficiency of Cre-mediated recombination was assessed with Southern blotting. All experiments with Icmt ∆/∆ cells were initiated three to four passages after the AdRSVCre infection. To produce mixed populations of Icmt flx/flx and Icmt ∆/∆ cells, Icmt flx/flx cells were infected with low titers of AdRSVCre (10 6 PFU/ml) and high titers (10 8 PFU/ ml) of AdRSVnlacZ (so that all of the cells in the dish would be infected with adenovirus).
Icmt activity assay. Icmt activity was measured with basehydrolysis assays with S-adenosyl-L-[methyl- 14 C]methionine as the methyl donor and either N-acetyl-S-geranylgeranyl-L-cysteine or farnesyl-K-Ras as the substrate. The accumulation of "methylatable substrates" in cell extracts was quantified by measuring the methylation of proteins in cell extracts in the presence of recombinant Ste14p (the yeast ortholog of Icmt) and S-adenosyl-L-[methyl-14 C]methionine (24) .
Analyzing fibroblast growth. Anchorage-dependent growth was assessed with a tetrazolium compound (MTS)-based cell proliferation assay (Cell Titer 96 AQueous One Solution Cell Proliferation Assay; Promega Corp., Madison, Wisconsin, USA). Icmt flx/flx and Icmt ∆/∆ cells were seeded on 96-well plates (500 or 1,000 cells/well, n = 12 wells/cell line, 1 plate per time point) and incubated at 37°C. At various time points, 20 µl of the MTS reagent ([3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)]-2H-tetrazolium, inner salt) was added to each well and incubated for 2 hours at 37°C. Cell density was quantified by analyzing absorbance at 490 nm. The relative growth rates of Icmt flx/flx and Icmt ∆/∆ cells also were assessed with Southern blots to compare the relative intensities of Icmt flx and Icmt ∆ bands at different passages. Cells were passaged 1:10 every 4 days; the intensities of bands on Southern blots were quantified with a phosphorimager.
Analyzing growth of hepatocytes in vitro. To fully inactivate Icmt in the liver (i.e., obtain nearly complete levels of recombination in the liver), Icmt flx/flx mice harboring the inducible Mx1-Cre transgene (29) were injected intraperitoneally with polyinosinic-polycytidylic ribonucleic acid (pI-pC; Sigma-Aldrich, St. Louis, Missouri, USA) (300 µg every other day for a total of four injections). To generate mice with partial recombination in the liver (i.e., mice whose livers contained a mixture of Icmt flx/flx and Icmt ∆/∆ hepatocytes), mice were given a single pI-pC injection (200-500 µg). In the latter mice, the relative rates of Icmt flx/flx and Icmt ∆/∆ cell proliferation were assessed after a partial hepatectomy (30) . To gain insight into the relative growth rates of Icmt flx/flx and Icmt ∆/∆ hepatocytes, Southern blotting was used to compare the ratio of Icmt flx and Icmt ∆ alleles at the time of partial hepatectomy and 10 days later, when liver regeneration was complete.
Analysis of anchorage-independent growth. The ability of K-Ras-Icmt ∆/∆ and parental K-Ras-Icmt flx/flx fibroblasts to form colonies in soft agar was analyzed in side-byside experiments. For these studies, K-Ras-Icmt ∆/∆ fibroblasts were produced from K-Ras-Icmt flx/flx fibroblasts with AdRSVCre (10 8 PFU/ml). Control K-RasIcmt flx/flx fibroblasts were infected with 10 8 PFU/ml of AdRSVnlacZ. The K-Ras-Icmt ∆/∆ and K-Ras-Icmt flx/flx fibroblasts (500-10,000 cells) were placed in medium containing 0.35% agarose and then poured onto 12-well plates containing a 0.70% agarose base. After the plates had been incubated at 37°C for 21-30 days, the colonies were stained with 3-[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide (thiazolyl blue, MTT; Sigma-Aldrich) and photographed. The number of colonies was quantified with an image-processing tool kit in Adobe Photoshop 6.0 (21) .
Assay of tumorigenicity in nude mice. To assess the relative capacities of K-Ras-Icmt ∆/∆ and parental K-Ras-Icmt flx/flx fibroblasts to form tumors in nude mice, a mixed population of K-Ras-Icmt flx/flx and K-Ras-Icmt ∆/∆ fibroblasts was generated by treating K-Ras-Icmt flx/flx fibroblasts with a low-titer AdRSVCre (10 6 PFU/ml) as already Subcellular fractionation to assess membrane targeting of the Ras proteins. S100 (cytosolic) and P100 (membrane) fractions of K-Ras-Icmt ∆/∆ and K-Ras-Icmt flx/flx cells were prepared, and Ras proteins were immunoprecipitated as described (21 (20) . Transfections were carried out with SuperFect Reagent (QIAGEN Inc., Valencia, California, USA). Cells were fixed in 4% formalin 24-28 hours after transfection, mounted, and viewed with a Bio-Rad MRC-600 laser scanning confocal imaging system (Bio-Rad Laboratories Inc., Hercules, California, USA).
Coimmunoprecipitation of p21 Cip1 and cyclin A. Cyclin A was immunoprecipitated from 1.0 mg of total cell protein from extracts of K-Ras-Icmt ∆/∆ and K-Ras-Icmt f lx/flx cells with a polyclonal antibody (H-432; Santa Cruz Biotechnology Inc., Santa Cruz, California, USA) and resolved on 10-20% SDS-PAGE gels. To detect cyclin A-associated p21 Cip1 , immunoblots were then performed with an anti-p21 Cip1 antibody (F-5; Santa Cruz Biotechnology Inc.). Mitogen-activated protein (MAP) kinase signaling. Serum-and EGF-stimulated phosphorylation of the downstream Ras effectors Erk1/2 and Akt1 was assessed by seeding 10 5 nontransfected Icmt flx/flx and derivative Icmt ∆/∆ cells (i.e., no activated K-Ras) on 60-mm dishes and then subjecting them to overnight serum starvation (in 0.5% serum). The next morning, medium containing 10% serum or 50 ng/ml human EGF (Sigma-Aldrich) was added to the cells. At various times after EGF stimulation, the cells were harvested and total cell extracts were analyzed by immunoblotting with antibodies recognizing phospho-Erk1/2 (phospho-p44/42 MAP kinase E10 mAb; Cell Signaling Technology, Beverly, Massachusetts, USA), phospho-Akt1 [(Ser 473)-R, polyclonal; Santa Cruz Biotechnology Inc.], and total Erk1/2 (p44/42 MAP kinase, polyclonal; Cell Signaling Technology).
Analysis of turnover of Rho and Ras proteins. To assess the impact of the
Northern blotting and cDNA probes. Northern blots were performed with standard techniques (31) on total cellular RNA extracted with the TRI reagent (Sigma-Aldrich). A mouse Kras2 cDNA probe was amplified from a mouse liver cDNA library (CLON-TECH Laboratories Inc., Palo Alto, California, USA) with forward primer 5′-AAAGCGGAGAGAGGCCTGCT-GAAAATG-3′ and reverse primer 5′-ACCATAGGCA-CATCTTCAGAGTCC-3′. A mouse RhoA (Ahra2) cDNA probe was amplified from the mouse liver cDNA library with forward primer 5′-ACTGGTGATTGTTG-GTGATGGAGC-3′ and reverse primer 5′-TCATTCC-GAAGGTCCTTCTTGTTCCC-3′. A mouse p21 Cip1 (Cdkn1a) cDNA probe was amplified from the mouse liver cDNA library with forward primer 5′-AAAAGCACCTG-CAAGACCAGAGGG-3′ and reverse primer 5′-TTAAG-TTTGGAGACTGGGAGAGGG-3′. 
Generation of Cdkn1a-deficient Icmt
Results
Creation of Icmt-deficient fibroblast cell lines.
To assess the importance of Icmt for cell growth and Ras transformation, we created a conditional Icmt-knockout allele in which exon 1 and upstream promoter sequences were flanked by loxP sites (Figure 1a ). Two independent ES cell lines (each with a single neo integration) were used to create chimeric mice, which were bred to produce heterozygous mice (Icmt +/flx ). When Icmt +/flx mice were intercrossed, homozygous mice (Icmt flx/flx ) were born at the predicted mendelian frequency and were fertile and healthy. Fibroblasts from Icmt flx/flx embryos were immortalized as described in the Methods section. Cre-mediated excision of the floxed segment of Icmt resulted in the production of Icmt ∆/∆ cells (Figure 2b) . If the Icmt inactivation had no effect on cell growth (i.e., if there were no differences in the competitive fitness of Icmt flx/flx and Icmt ∆/∆ cells), one would expect that the Southern blots would reveal stability-at different passages-in the relative intensities of the Icmt flx and Icmt ∆ bands. This was not the case. In each experiment, the ratio of the Icmt flx band to the Icmt ∆ band increased in later passages, indicating a competitive growth advantage of the parental Icmt flx/flx cells over the Icmt ∆/∆ cells (Figure 2b) .
Inactivating Icmt also interfered with the growth of hepatocytes in vivo. We bred Icmt flx/flx mice with mice harboring the inducible Mx1-Cre transgene and then administered a single intraperitoneal injection of pI-pC. A single pI-pC injection causes incomplete recombination in the liver; thus, the livers of these mice contained a mixed population of Icmt flx/flx and Icmt ∆/∆ hepatocytes. Two weeks later, we performed a partial hepatectomy, which triggers hepatocyte proliferation. To gauge the relative capacities of Icmt flx/flx and Icmt ∆/∆ hepatocytes to contribute to liver regeneration, we used Southern blots to measure the ratio of the 7-kb Icmt flx band to the 4.8-kb Icmt ∆ band in liver genomic DNA, both at baseline (at the time of the partial hepatectomy) and 10 days later when liver regeneration was complete. After liver regeneration, the ratio of the Icmt flx band to the Icmt ∆ band invariably increased, indicating that Icmt flx/flx hepatocytes contributed more than the Icmt ∆/∆ hepatocytes to liver regrowth (Figure 2c ; P < 0.01, n = 5). This difference could not be attributed to hepatocyte death due to the Icmt knockout. By treating Icmt flx/flx mice with four intraperitoneal injections of pI-pC, we readily generated mice in which Cre-mediated recombination in the liver was virtually complete. In those mice, plasma transaminases remained normal, and there was no histological evidence of hepatocyte necrosis (not shown). (Figure 5a ). Also, a large portion of the K-Ras in K-RasIcmt ∆/∆ fibroblasts was present in the soluble (S100) fraction of cells, whereas nearly all of the K-Ras in the parental K-Ras-Icmt flx/flx fibroblasts was associated with the membrane (P100) fraction (Figure 5b) . Notably, inactivation of Icmt in the K-Ras-Icmt f lx/flx fibroblasts invariably caused about a twofold increase in steady-state levels of total Ras proteins and GTPbound Ras proteins within cells ( Figure 5, b and c) , while the ratio of total to GTP-bound Ras remained constant (not shown). The higher levels of the Ras proteins could not be explained by higher levels of mouse K-Ras or human K-Ras mRNA (Figure 5d ) and are apparently due to a decreased turnover of Ras in these cells (see later).
Inhibition of K-Ras transformation in
The inactivation of Icmt in nontransfected cells (i.e., no activated K-Ras) did not affect serum growth factor-stimulated or EGF-stimulated phosphorylation of the downstream Ras effectors, Erk1/2 and Akt1 ( Figure  6, a and b) . These results indicate that the absence of carboxyl methylation of CAAX proteins in Icmt-deficient cells has prominent effects on Ras targeting to membranes and on the steady-state levels of Ras proteins in cells, but apparently little or no effect on the growth factor-stimulated activation of Erk1/2 and Akt.
Accelerated turnover of Rho proteins in Icmt ∆/∆ fibroblasts. The Rho GTPases play important roles in cell-cycle progression and cell transformation (33) (34) (35) . Rho proteins are CAAX proteins that, like the Ras proteins, undergo Icmt-mediated methylation. We hypothesized that the slow growth of Icmt ∆/∆ fibroblasts and their resistance to K-Ras transformation might be accompanied by a defect in Rho metabolism and signaling. Indeed, our data suggest that this was the case. The steady-state levels of total RhoA and GTP-bound RhoA in K-Ras-Icmt ∆/∆ fibroblasts were only about 5-10% of those in the parental K-Ras-Icmt flx/flx cells 
Figure 6
Growth factor-stimulated Erk1/2 and Akt1 phosphorylation in Icmtdeficient fibroblasts. (a) Nontransfected Icmt flx/flx and the derivative Icmt ∆/∆ fibroblasts were seeded at equal density and serum-starved overnight as described in the Methods section. Serum-containing medium was then added to the cells. Cells were harvested at the indicated time points and analyzed by immunoblotting with antibodies against phosphorylated Erk1/2 (p-Erk1/2), phosphorylated Akt1 (p-Akt1), and total Erk1/2. (b) Icmt flx/flx and the derivative Icmt ∆/∆ fibroblasts were seeded at equal density and serum-starved overnight. Medium (0.5% serum) supplemented with EGF (50 ng/ml) was added to the cells. Cells were harvested at the indicated time points and analyzed by immunoblotting with antibodies against p-Erk1/2 and total Erk1/2. Upregulation of p21 Cip1 in K-Ras-transfected Icmt ∆/∆ fibroblasts. The regulatory protein p21 Cip1 binds to cyclins and inhibits cell-cycle progression (35, 36) . p21 Cip1 levels are upregulated by overexpression of activated Ras, but this Ras-induced upregulation can be antagonized by RhoA (32, 34) . In light of the low levels of RhoA in K-RasIcmt ∆/∆ fibroblasts, we hypothesized that those cells might exhibit higher levels of p21 Cip1 . Indeed, p21 Cip1 levels in K-Ras-Icmt ∆/∆ cells were more than fourfold higher in K-Ras-Icmt ∆/∆ cells than in the parental K-Ras-Icmt flx/flx cells (Figure 9a , P < 0.01). The increase in p21 Cip1 protein levels in K-Ras-Icmt ∆/∆ fibroblasts was accompanied by a 1.4-fold increase in p21 Cip1 mRNA levels (Figure 9b , P < 0.001). The increase in p21 Cip1 protein levels was not ( Figure 7 , a and b, P < 0.001). This finding was clearly due to absence of Icmt activity, since K-Ras-Icmt ∆/∆ fibroblasts expressing the human ICMT cDNA exhibited normal levels of GTP-bound RhoA (Figure 7a) . The low levels of RhoA protein in K-Ras-Icmt ∆/∆ fibroblasts were not accompanied by a comparable reduction in the levels of RhoA mRNA (Figure 7c ).
To determine if accelerated Rho turnover was responsible for the low levels of RhoA in the K-Ras-Icmt ∆/∆ fibroblasts, we used metabolic labeling/pulse-chase observed in K-Ras-Icmt ∆/∆ cells expressing a human ICMT cDNA (Figure 9c ). The increased level of p21 Cip1 in K-Ras-Icmt ∆/∆ fibroblasts was accompanied by an increased association between p21 Cip1 and cyclin A (Figure 9a, middle panel) . To test whether signaling through the Erk1/2 pathway was involved in the upregulation of p21 Cip1 , we treated K-Ras-Icmt ∆/∆ fibroblasts and the parental K-Ras-Icmt flx/flx cells with the MEK inhibitor PD98059. PD98059 decreased p21 Cip1 levels in the K-RasIcmt ∆/∆ fibroblasts, but it did not affect p21 Cip1 levels in the K-Ras-Icmt flx/flx fibroblasts (Figure 9d ). This result does not prove that Ras signaling is involved in the upregulation of p21 Cip1 . However, in nontransfected Icmt ∆/∆ fibroblasts, the levels of p21 Cip1 were similar to those in the parental Icmt flx/flx fibroblasts (not shown). These data suggest that increased Ras signaling through the Erk1/2 pathway could be responsible for the upregulation of p21 Cip1 in K-Ras-Icmt ∆/∆ fibroblasts.
Knocking out p21 Cip1 restores the capacity of K-Ras-trans-
fected Icmt ∆/∆ fibroblasts to grow in soft agar. The finding that p21 Cip1 levels were elevated in K-Ras-Icmt ∆/∆ fibroblasts suggested that p21 Cip1 might be important for the markedly reduced oncogenic capacity of these cells. To test this hypothesis, we generated p21 Cip1 -deficient K-Ras-Icmt flx/flx fibroblasts and then used AdRSVCre to produce p21 Cip1 -deficient K-Ras-Icmt ∆/∆ fibroblasts (Figure 10a ). In the absence of p21 Cip1 , the inactivation of Icmt no longer blocked the ability of K-Ras-transfected cells to grow in soft agar (Figure 10b) . Similarly, in the absence of p21 Cip1 , there was no difference in the growth rate of K-Ras-Icmt ∆/∆ and K-Ras-Icmt flx/flx fibroblasts under routine cell-culture conditions (anchorage-dependent growth) (not shown).
Inactivation of Icmt blocks B-Raf-induced cellular transformation.
To determine if the effect of the Icmt inactivation was limited to inhibiting the growth of K-Rastransformed fibroblasts, we analyzed the effect of inactivating Icmt in Icmt flx/flx cells that had been infected with a retrovirus encoding a mutationally activated form of human B-Raf (V599E). B-Raf-Icmt flx/flx fibroblasts grew faster than nontransfected cells, lost contact inhibition, and were capable of forming colonies in soft agar (Figure 11 ). AdRSVCre-mediated deletion of Icmt from B-Raf-Icmt flx/flx fibroblasts (to produce B-Raf-Icmt ∆/∆ fibroblasts) restored contact inhibition and eliminated the ability of the cells to grow in soft agar ( Figure 11 ). In addition, B-Raf-transfected Icmt -/-fibroblasts did not form colonies in soft agar, whereas B-Raf-transfected Icmt +/+ fibroblasts did (not shown).
Discussion
In the current study, we show that inactivation of Icmt in mouse fibroblasts results in slow growth and a striking reduction in oncogenic transformation induced by K-Ras and B-Raf. For the K-Ras-transfected fibroblasts we also provide evidence that the absence of carboxyl methylation results in a rapid turnover of RhoA and an upregulation of the cyclin-dependent kinase inhibitor p21 Cip1 . These phenotypes were abrogated by the ectopic expression of a human ICMT cDNA. In addition, the finding that deletion of Cdkn1a (the gene encoding p21 Cip1 ) abolished the effects of the Icmt inactivation on cell growth and K-Ras-induced colony formation in soft agar, suggests that the Icmt knockout-mediated inhibition of cell growth and K-Ras transformation requires p21 Cip1 .
Cre-mediated inactivation of Icmt caused a 90-95% reduction in K-Ras-induced colony growth in soft agar and a reduced capacity to contribute to tumor growth in nude mice. This phenotype is almost certainly due to inactivation of Icmt rather than to an artifact related to adenoviral infection-for several reasons. First, all of the control cells for these experiments were treated with an adenovirus encoding β-gal. Second, the adenovirus treatment was temporally remote from the actual experiments; all of the transformation experiments were performed at least three or four passages-more than 20 cell divisions-after adenoviral infection. Third, Cre-mediated inactivation of Icmt had no detectable effects in cells that had been previously transfected with a cDNA encoding human ICMT. Fourth, we obtained very similar cell growth and transformation results with conventional Icmt-knockout fibroblasts (Icmt -/-cells), which were not treated with adenovirus. Finally, we previously showed that Cre-adenovirus infection, under the conditions used here, did not change the growth rate of fibroblasts (21) .
It is widely believed that targeting of Ras proteins to the plasma membrane is very important for downstream signaling cascades. Icmt deficiency caused a striking mislocalization of GFP-K-Ras away from the plasma membrane, as well as a redistribution of Ras proteins to the cytosolic fraction. However, the mislocalization of K-Ras was not accompanied by detectable decreases in growth factor-stimulated activation of Erk1/2 and Akt1. We have made identical observations in Rce1-deficient cells-a striking mislocalization of Ras proteins (21) but no apparent effect on Erk1/2 signaling (E. Kim et al., unpublished observations). We do not yet fully understand why the mislocalization of Ras proteins is not accompanied by detectable changes in signaling, but several possibilities exist. First, growth factor stimulation of Erk1/2 and Akt1 in Icmt-deficient cells may simply be mediated by non-Ras pathways. Second, it is possible that a small percentage of the Ras proteins make it to the plasma membrane in Icmt-deficient cells and that this small amount of normally targeted Ras is sufficient for the signaling "readouts". Another possibility is that some of the Ras proteins in Icmt-deficient cells are mislocalized to the Golgi or ER membranes and that signaling occurs fairly normally from those locations. This explanation is not farfetched. It was recently shown that Ras targeted to the Golgi or ER was able to recruit Raf-1, activate the Erk pathway, and transform fibroblasts (37) .
The fact that growth factor-stimulated Erk1/2 and Akt signaling was normal in the setting of Icmt deficiency prompted us to seek other explanations for the retarded cell growth and the reduced capacity of K-Ras-transfected cells to form colonies in soft agar. The Rho proteins are required for Ras transformation and are sometimes found at increased concentrations in Ras-transformed cells (35, 38) . Because the Rho proteins are also substrates for Icmt, we asked whether Icmt deficiency might perturb Rho metabolism. Indeed, this was the case. The steadystate levels of GTP-bound RhoA and total RhoA were lower in the Icmt ∆/∆ fibroblasts than in the parental Icmt flx/flx cells, as a result of accelerated protein turnover. These findings were consistent with earlier results from Backlund (39) . He used a combination of pulse-chase studies and two-dimensional gel electrophoresis to show that nonmethylated RhoA is less stable than the methylated form. Notably, the effect of methylation on protein stability can be very different for other CAAX proteins; the Ras proteins in Icmt ∆/∆ cells were actually more stable than the Ras proteins in Icmt flx/flx cells. In the case of the Ras proteins, one might reasonably hypothesize that normal Ras turnover occurs only at certain membrane surfaces, and that changes in Ras partitioning within the cell would have secondary effects on protein degradation. The finding of increased Ras levels is consistent with data from Holstein et al. (40) . They found that Ras protein levels increase after mevalonate depletion, which inhibits isoprenylation of CAAX proteins. However, in their experiments, RhoA protein levels also increased. Thus, isoprenylation and carboxylmethylation could have opposite effects on the steady-state levels of RhoA.
Data from Olson et al. (36) suggest that constitutive Ras signaling in the absence of Rho increases p21 Cip1 levels, leading to cell-cycle arrest. Microinjection of activated Ras into fibroblasts increased DNA synthesis, whereas the simultaneous microinjection of Ras and a specific Rho inhibitor (C3 exoenzyme) increased p21 Cip1 and inhibited DNA synthesis (36) . In our studies, the inactivation of Icmt in K-Ras-transfected fibroblasts was associated with a striking reduction in RhoA protein levels and a 4.2-fold upregulation of p21 Cip1 . We predicted that the upregulation of p21 Cip1 might be an important influence in the reduced capacity of Icmt-deficient fibroblasts to grow in soft agar. Indeed, this seemed to be the case. When we performed experiments with K-Ras-Icmt flx/flx cells lacking p21 Cip1 (K-Ras-Icmt flx/flx Cdkn1a -/-), we found that Cre-mediated inactivation of Icmt had no measurable effect on cell growth on plastic plates or on the growth of colonies in soft agar. Notably, both FTase inhibitors and GGTase I inhibitors have been reported to increase p21 Cip1 levels in human tumor cells (41, 42) .
Our results indicate that the effect of the Icmt inactivation on K-Ras transformation may have been a consequence of its effects on Rho and p21 Cip1 rather than being due to a direct effect on the intrinsic properties of K-Ras itself. To explore this issue further, we examined the consequences of inactivating Icmt in cells that had been transformed with mutationally activated B-Raf, a downstream Ras effector. Activating mutations in B-Raf have been identified in 66% of malignant melanomas (43) . B-Raf is not a CAAX protein and hence not a substrate for Icmt, yet the Cremediated inactivation of Icmt reversed the transformed phenotypes in B-Raf-transfected cells. This finding is in keeping with the notion that the reversion of K-Ras transformation may not have been due to a direct effect on K-Ras.
The current study supports the idea that Icmt could be a therapeutic target for treating cancer. Perhaps more importantly, however, the current study has created a tool for addressing this issue. With the creation of mice harboring a conditional Icmt allele, it is now possible to test whether a deficiency in Icmt would retard tumor growth in vivo. Several groups have developed "latent oncogenes" that can be activated in vivo by expressing Cre, resulting in the formation of tumors (44, 45) . In those mice, it would be of value to determine if the Cre-induced tumor development could be prevented by the simultaneous inactivation of Icmt.
